Основная статистика
| CIK | 1532923 |
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis.
These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to Kissei Pharmaceutical Co., Ltd.
SEC Filings (Chronological Order)
На этой странице представлен полный хронологический список документов SEC, за исключением документов о собственности, которые мы предоставляем в других местах.
| March 14, 2024 |
CGON / CG Oncology, Inc. / Kissei Pharmaceutical Co., Ltd. - SC 13G Passive Investment SC 13G 1 d765679dsc13g.htm SC 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* CG Oncology, Inc. (Name of Issuer) Common Stock, $0.0001 par value per share (Title of Class of Securities) 156944100 (CUSIP Number) January 29, 2024 (Date of Event Which Requires Filing of This Statement) Check the appro |
|
| June 14, 2017 |
MNOV / Medicinova, Inc. / Kissei Pharmaceutical Co., Ltd. - SC 13D/A Activist Investment SC 13D/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 2)* MediciNova, Inc. (Name of Issuer) Common Stock, par value $0.001 per Share (Title of Class of Securities) 58468P206 (CUSIP Number) Hiroe Satou Member of the Board and Senior Director, Corporate Finance & Management KISSEI PHARMACEUTICAL CO., LTD |
|
| May 17, 2016 |
Schedule 13D (Amendment No. 1) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 1)* MediciNova, Inc. (Name of Issuer) Common Stock, par value $0.001 per Share (Title of Class of Securities) 58468P206 (CUSIP Number) Hiroe Satou Member of the Board and Senior Director, Corporate Finance & Management KISSEI P |
|
| October 19, 2011 |
Schedule 13D UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. )* MediciNova, Inc. (Name of Issuer) Common Stock, par value $0.001 per Share (Title of Class of Securities) 58468P206 (CUSIP Number) Hiroe Satou Member of the Board and Senior Director, Corporate Finance & Management KISSEI PHARMACEUTICAL CO., |
